Co-Authors
This is a "connection" page, showing publications co-authored by RALF KRAHE and KEITH A BAGGERLY.
Connection Strength
0.516
-
Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer. 2011 Feb 01; 117(3):606-17.
Score: 0.094
-
Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One. 2009; 4(3):e4941.
Score: 0.084
-
Molecular signatures of metastasis in head and neck cancer. Head Neck. 2008 Oct; 30(10):1273-83.
Score: 0.081
-
Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics. 2008 May 12; 9:216.
Score: 0.079
-
Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques. 2003 Jul; 35(1):146-50.
Score: 0.057
-
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord. 2014 Mar; 24(3):227-40.
Score: 0.029
-
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet. 2011 Jul; 19(7):776-82.
Score: 0.024
-
Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders. Muscle Nerve. 2010 Dec; 42(6):856-63.
Score: 0.024
-
Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol. 2010 Apr; 119(4):465-79.
Score: 0.022
-
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain. 2009 Aug; 132(Pt 8):2277-88.
Score: 0.021